![These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral useInitial U.S. Approval: 2002 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral useInitial U.S. Approval: 2002](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=afe9596b-3231-4248-891c-5f2f9e6dd83a-07.jpg&id=729295)
These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral useInitial U.S. Approval: 2002
![JPM | Free Full-Text | Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial JPM | Free Full-Text | Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial](https://pub.mdpi-res.com/jpm/jpm-11-01188/article_deploy/html/images/jpm-11-01188-ag.png?1637027084)
JPM | Free Full-Text | Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
![Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/wpengine/uploads/19-prescribing-information-citalopram-escitalopram-300x168.png)
Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute
![Frontiers | CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population Frontiers | CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population](https://www.frontiersin.org/files/Articles/730461/fphar-12-730461-HTML/image_m/fphar-12-730461-g001.jpg)
Frontiers | CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
![A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss | JPN A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss | JPN](https://www.jpn.ca/content/jpn/46/3/E319/F2.large.jpg)
A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss | JPN
![Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/wpengine/uploads/17-qtc-prolongation-escitalopram-300x168.png)
Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute
![Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute Citalopram and Escitalopram: MOA, Indications, Pharmacokinetics and Dosing - Psychopharmacology Institute](https://cdn.psychopharmacologyinstitute.com/wpengine/uploads/15-QT-PROLONGATION-CITALOPRAM-ESCITALOPRAM-300x168.png)